Utah Medical Products, Inc. (UTMD)

Utah Medical Products Market Cap

Utah Medical Products has a market cap or net worth of $236.59 million as of April 26, 2024. Its market cap has decreased by -31.36% in one year.

• Market Cap: 236.59M
• Enterprise Value: 144.01M
• 1-Year Change: -31.36%
• Ranking: #3507
• Category: Micro-Cap
• Stock Price: $65.92

Market Cap Chart

Since March 8, 1999, Utah Medical Products's market cap has increased from $49.30M to $236.59M, an increase of 379.89%. That is a compound annual growth rate of 6.43%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	237.90M	-1.29%
Apr 24, 2024	241.00M	-0.62%
Apr 23, 2024	242.50M	-0.82%
Apr 22, 2024	244.50M	-0.65%
Apr 19, 2024	246.10M	1.99%
Apr 18, 2024	241.30M	-0.58%
Apr 17, 2024	242.70M	-0.74%
Apr 16, 2024	244.50M	-0.33%
Apr 15, 2024	245.30M	-0.45%
Apr 12, 2024	246.40M	-2.14%
Apr 11, 2024	251.80M	0.04%
Apr 10, 2024	251.70M	-1.22%
Apr 9, 2024	254.80M	1.43%
Apr 8, 2024	251.20M	1.33%
Apr 5, 2024	247.90M	0.77%
Apr 4, 2024	246.00M	-0.16%
Apr 3, 2024	246.40M	-1.04%
Apr 2, 2024	249.00M	-1.93%
Apr 1, 2024	253.90M	-0.51%
Mar 28, 2024	255.20M	1.31%
Mar 27, 2024	251.90M	2.98%
Mar 26, 2024	244.60M	-2.82%
Mar 25, 2024	251.70M	1.12%
Mar 22, 2024	248.90M	0.08%
Mar 21, 2024	248.70M	-2.24%

View and export this data all the way back to 1999. Sign Up Today.

Related Stocks

Company	Market Cap
Adaptimmune Therapeutics	245.34M
Nektar Therapeutics	241.46M
Puma Biotechnology	241.04M
Verastem	239.55M
XBiotech	238.13M
AC Immune	235.10M
Aldeyra Therapeutics	234.69M
Ventyx Biosciences	233.60M